Design, synthesis, structure–activity relationship studies, and evaluation of novel GLS1 inhibitors-Reference-Cited by-同舟云学术

Design, synthesis, structure–activity relationship studies, and evaluation of novel GLS1 inhibitors

Published:2023-05 Issue: Volume:87 Page:129266
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Jo Michiko,Koizumi Keiichi^ORCID,Suzuki Mizuho,Kanayama Daisuke,Watanabe Yurie,Gouda Hiroaki,Mori Hisashi^ORCID,Mizuguchi Mineyuki,Obita Takayuki,Nabeshima Yuko,Toyooka Naoki,Okada Takuya^ORCID

Funder

Japan Science and Technology Agency

University of Toyama

Institute of Natural Medicine, University of Toyama

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference20 articles.

1. Famine versus feast: understanding the metabolism of tumors in vivo;Mayers;Trends in Biochemical Sciences,2015

2. From Krebs to clinic: glutamine metabolism to cancer therapy;Altman;Nature Reviews. Cancer,2016

3. Molecular mechanisms of glutamine action;Curi;Journal of Cellular Physiology,2005

4. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer;Gross;Molecular Cancer Therapeutics,2014

5. Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders;Johmura;Science,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CB-839 induces reversible dormancy in lung tumor-cells;European Journal of Pharmacology;2024-11

2. Design and structural optimization of thiadiazole derivatives with potent GLS1 inhibitory activity;Bioorganic & Medicinal Chemistry Letters;2023-09